NEW YORK (GenomeWeb News) – Cepheid disclosed in its Form 10-Q filed with the US Securities and Exchange Commission this week that it paid $18.5 million during the first six months of the year to acquire one of its distributors and certain assets of another distributor. A company spokesperson decline to provide further comment or identify the names of the purchased assets.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.